The Heterogeneous Nature of White-Coat Hypertension

Journal of the American College of Cardiology

Volumn 68, Issue 19, 2016, Pages 2044-2046

  Mancia, Giuseppe ^a,b   Grassi, Guido ^a,c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

Author keywords

aging; blood pressure; cardiovascular risk; prognosis; risk factors; stress

Indexed keywords

COHORT ANALYSIS; DIABETES MELLITUS; EDITORIAL; FOLLOW UP; HEART RATE; HUMAN; LIMIT OF QUANTITATION; ORTHOSTATIC HYPOTENSION; POPULATION RESEARCH; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; WELLBEING; WHITE COAT HYPERTENSION; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; HYPERTENSION; MASKED HYPERTENSION;

BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; HUMANS; HYPERTENSION; MASKED HYPERTENSION; WHITE COAT HYPERTENSION;

EID: 84994097626     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.08.043     Document Type: Editorial

References (17)

1. 1 Kleinert, H.D., Harshfield, G.A., Pickering, T.G., et al. What is the value of home blood pressure measurement in patients with mild hypertension?. Hypertension 6 (1984), 574–578.
2. 2 National Clinical Guideline Centre. Hypertension. The Clinical Management of Primary Hypertension in Adults. Update of Guidelines 18 and 24. NICE Clinical Guideline 127. 2011, National Institute for Health and Clinical Excellence (NICE), London, UK Available at: https://www.guideline.gov/summaries/summary/34824 Accessed August 25, 2016.
3. 3 Mancia, G., Facchetti, R., Bombelli, M., et al. Long-term risk mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 47 (2006), 846–853.
4. 4 Pierdomenico, S.D., Cuccurullo, F., Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 24 (2011), 52–58.
5. 5 Tientcheu, D., Ayers, C., Das, S.R., et al. Target organ complications and cardiovascular events associated with masked hypertension and white-coat hypertension: analysis from the Dallas Heart Study. J Am Coll Cardiol 66 (2015), 2159–2169.
6. 6 Franklin, S.S., Thijs, L., Asayama, K., et al., IDACO Investigators. The cardiovascular risk of white-coat hypertension. J Am Coll Cardiol 68 (2016), 2033–2043.
7. 7 Mancia, G., Fagard, R., Narkiewicz, K., et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31 (2013), 1281–1357.
8. 8 Mancia, G., Clinical significance of white coat hypertension. J Hypertens 34 (2016), 623–626.
9. 9 Sehestedt, T., Jeppesen, J., Hansen, T.W., et al. Risk prediction is improved by adding markers of subclinical organ damage to SCORE. Eur Heart J 31 (2010), 883–891.
10. 10 Mancia, G., Facchetti, R., Grassi, G., et al. Adverse prognostic value of persistent office blood pressure elevation in white coat hypertension. Hypertension 66 (2015), 437–444.
11. 11 Mancia, G., Bombelli, M., Brambilla, G., et al. Long-term prognostic value of white coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements. Hypertension 62 (2013), 168–174.
12. 12 Franklin, S.S., Thijs, L., Hansen, T.W., et al., International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes Population. Hypertension 59 (2012), 564–571.
13. 13 Sega, R., Cesana, G., Milesi, C., et al. Ambulatory and home blood pressure normality in the elderly: data from the PAMELA population. Hypertension 30 (1997), 1–6.
14. 14 Verdecchia, P., Schillaci, G., Borgioni, C., et al. White coat hypertension and white coat effect. Similarities and differences. Am J Hypertens 8 (1995), 790–798.
15. 15 Mancia, G., Bertinieri, G., Grassi, G., et al. Effects of blood-pressure measurement by the doctor on patient's blood pressure and heart rate. Lancet 2 (1983), 695–698.
16. 16 Julius, S., Jamerson, K., Gudbrandsson, T., et al. White coat hypertension: a follow-up. Clin Exp Hypertens A 14 (1992), 45–53.
17. 17 Parati, G., Omboni, S., Staessen, J., et al., Syst-Eur investigators. Limitations of the difference between clinic and daytime blood pressure as a surrogate measure of the ‘white-coat’ effect. J Hypertens 16 (1998), 23–29.